Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients (PRO-CTCAE)
Translation, Cross-Cultural Adaptation and Validation of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for Italian-speaking Cancer Patients
Sponsor: F.A.V.O. Italian Federation of Volunteer-Based Cancer Organizations
Listed as NCT02381054, this observational or N/A phase trial focuses on Cancer and remains completed. Sponsored by F.A.V.O. Italian Federation of Volunteer-Based Cancer Organizations, it has been updated 9 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Oct 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Oct 2021 [monthly]
Completed
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- F.A.V.O. Italian Federation of Volunteer-Based Cancer Organizations
- Fondazione IRCCS Policlinico San Matteo di Pavia
- IRCCS AOU San Martino -IST Genoa
- Istituti Ospitalieri di Cremona
- Italian PRO-CTCAE Study Group
- National Cancer Institute, Naples
- Parma University Hospital
- SmithKline Foundation
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bari, Italy , Brindisi, Italy , Cremona, Italy , Genova, Italy , Messina, Italy , Milan, Italy , Napoli, Italy , Padua, Italy , Pavia, Italy , Roma, Italy and 4 more locations